Activation and Inhibition of Hageman Factor-Dependent Pathways and the Complement System in Uncomplicated Bacteremia or Bacterial Shock
- 31 May 1985
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 151 (6) , 1019-1027
- https://doi.org/10.1093/infdis/151.6.1019
Abstract
Levels of components of the contact activation, coagulation, and complement systems and their main inhibitors were measured in 45 critically ill patients during 61 episodes of uncomplicated bacteremia or bacterial shock. Levels of Hageman factor (factor XII), prekallikrein, high-molecular-weight kininogen, factor XI, factor VII, total hemolytic complement, alternative pathway activity, and C3 were within the normal range during uncomplicated bacteremia (n = 29), but during fatal bacterial shock (n = 13) a significant decrease by 40%–50% was observed in all measurements. During nonfatal bacterial shock (n = 19) a moderate decrease was observed in most of these measurements. The capacity of plasma to inactivate kallikrein was significantly higher during bacteremia than during bacterial shock because of a significant increase in the level of Cl esterase inhibitor. Levels of antithrombin III and α2-macroglobulin were below normal in all groups. Thus increased inhibition of the contact activation and complement systems is beneficial during bacteremia.Keywords
This publication has 17 references indexed in Scilit:
- ROLE OF STAPHYLOCOCCUS-AUREUS CELL-WALL PEPTIDOGLYCAN, TEICHOIC-ACID AND PROTEIN-A IN THE PROCESSES OF COMPLEMENT ACTIVATION AND OPSONIZATION1979
- Antithrombin III I. Evaluation of an automated antithrombin III methodThrombosis Research, 1978
- Plasma Kallikrein Activation and Inhibition during Typhoid FeverJournal of Clinical Investigation, 1978
- Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII.Journal of Biological Chemistry, 1977
- Activation of bovine factor VII (proconvertin) by factor XIIa (activated Hageman factor)Biochemistry, 1977
- KININ ACTIVATION IN BLOOD OF PATIENTS WITH SEPSIS1976
- Plasma Kallikrein and Hageman Factor in Gram-Negative BacteremiaAnnals of Internal Medicine, 1970
- The Stoichiometric Measurement of the Serum Inhibitor of the First Component of Complement by the Inhibition of Immune HemolysisThe Journal of Immunology, 1968
- SERUM INHIBITOR OF C'1-ESTERASE IN HEALTH AND DISEASE1966
- Effects of Bradykinin on Forearm Venous Tone and Vascular Resistance in ManCirculation Research, 1965